Targeted therapy of anaplastic thyroid cancer
Introduction. Anaplastic thyroid cancer (ATC) is a very rare malignant tumor of the thyroid comprising 1–2 % of all thyroid cancers. In this pathology, response rate for standard systemic therapy is less than 15 %, and long-term results remain unsatisfactory. Additionally, there are no data conclusi...
| 发表在: | Опухоли головы и шеи |
|---|---|
| Main Authors: | P. A. Nikiforovich, A. P. Polyakov, I. V. Sleptsov, N. S. Boyko, Yu. A. Gronskaya, N. I. Timofeeva, R. A. Chernikov |
| 格式: | 文件 |
| 语言: | 俄语 |
| 出版: |
ABV-press
2023-03-01
|
| 主题: | |
| 在线阅读: | https://ogsh.abvpress.ru/jour/article/view/841 |
相似书籍
Anaplastic thyroid cancer: current state of the problem
由: P. A. Nikiforovich, et al.
出版: (2025-05-01)
由: P. A. Nikiforovich, et al.
出版: (2025-05-01)
Systemic therapy for anaplastic thyroid cancer: a literature review
由: E. S. Dzhelialov, et al.
出版: (2025-01-01)
由: E. S. Dzhelialov, et al.
出版: (2025-01-01)
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
由: Matthias Lang, et al.
出版: (2023-03-01)
由: Matthias Lang, et al.
出版: (2023-03-01)
Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
由: A. L. Pylev, et al.
出版: (2020-04-01)
由: A. L. Pylev, et al.
出版: (2020-04-01)
Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas
由: A.C.L. Mortensen, et al.
出版: (2023-12-01)
由: A.C.L. Mortensen, et al.
出版: (2023-12-01)
TREATMENT OF <em>BRAF</em><sup>V600E</sup> POSITIVE ANAPLASTIC THYROID CARCINOMA: CASE REPORT
由: P. A. Nikiforovich, et al.
出版: (2020-10-01)
由: P. A. Nikiforovich, et al.
出版: (2020-10-01)
The role of surgery for anaplastic thyroid carcinoma in the era of targeted therapeutics: A scoping review
由: Eoin F. Cleere, et al.
出版: (2023-12-01)
由: Eoin F. Cleere, et al.
出版: (2023-12-01)
Immunotherapy in anaplastic thyroid cancer: Case series
由: Shyang-Rong Shih, et al.
出版: (2022-06-01)
由: Shyang-Rong Shih, et al.
出版: (2022-06-01)
Progress of Targeted Therapy for Anaplastic Thyroid Cancer
由: Detao YIN, et al.
出版: (2024-08-01)
由: Detao YIN, et al.
出版: (2024-08-01)
Visceral Perforation Complicating BRAF/MEK Targeted Therapy of Papillary Thyroid Carcinoma with Anaplastic Areas
由: Simon L. Barry, et al.
出版: (2024-12-01)
由: Simon L. Barry, et al.
出版: (2024-12-01)
Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy
由: Zhao Zou, et al.
出版: (2025-07-01)
由: Zhao Zou, et al.
出版: (2025-07-01)
Anticancer drug therapy for anaplastic thyroid cancer
由: Naomi Kiyota, et al.
出版: (2025-04-01)
由: Naomi Kiyota, et al.
出版: (2025-04-01)
Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer
由: Kazumasa Sekihara, et al.
出版: (2024-06-01)
由: Kazumasa Sekihara, et al.
出版: (2024-06-01)
Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma
由: Sabine Wächter, et al.
出版: (2025-08-01)
由: Sabine Wächter, et al.
出版: (2025-08-01)
Combination therapy of TKIs and ICIs for the treatment of anaplastic thyroid carcinoma
由: Xi Zhang, et al.
出版: (2025-05-01)
由: Xi Zhang, et al.
出版: (2025-05-01)
Case report: Complete response of an anaplastic thyroid carcinoma patient with NRAS Q61R/BRAF D594N mutations to the triplet of dabrafenib, trametinib and PD-1 antibody
由: Lin Gui, et al.
出版: (2023-04-01)
由: Lin Gui, et al.
出版: (2023-04-01)
NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma
由: Amir Hossein Karimi, et al.
出版: (2025-06-01)
由: Amir Hossein Karimi, et al.
出版: (2025-06-01)
Post-translational modifications in anaplastic thyroid carcinoma: biological mechanisms and therapeutic potential
由: Linkun Zhong, et al.
出版: (2025-10-01)
由: Linkun Zhong, et al.
出版: (2025-10-01)
Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 88 Cases
由: LIU Jingjing, et al.
出版: (2019-05-01)
由: LIU Jingjing, et al.
出版: (2019-05-01)
Management of anaplastic thyroid cancer and proposed treatment guidelines—A 5‐year case series study
由: Kento Koda, et al.
出版: (2022-11-01)
由: Kento Koda, et al.
出版: (2022-11-01)
Anaplastic thyroid cancer: current capabilities of an oncologist
由: A. L. Pylev, et al.
出版: (2023-06-01)
由: A. L. Pylev, et al.
出版: (2023-06-01)
The prevalence of DNA microsatellite instability in anaplastic thyroid carcinoma – systematic review and discussion of current therapeutic options
由: Maria Linda Rocha, et al.
出版: (2021-10-01)
由: Maria Linda Rocha, et al.
出版: (2021-10-01)
Anaplastic thyroid cancer
由: Javier Martínez Navarro, et al.
出版: (2017-10-01)
由: Javier Martínez Navarro, et al.
出版: (2017-10-01)
New opportunities for preoperative diagnosis of anaplastic thyroid cancer
由: S. A. Lukyanov, et al.
出版: (2021-04-01)
由: S. A. Lukyanov, et al.
出版: (2021-04-01)
Synergistic effects of the combination of trametinib and alpelisib in anaplastic thyroid cancer with BRAF and PI3KCA co-mutations
由: Chiao-Ping Chen, et al.
出版: (2024-04-01)
由: Chiao-Ping Chen, et al.
出版: (2024-04-01)
Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
由: Sun Hwa Kim, et al.
出版: (2013-03-01)
由: Sun Hwa Kim, et al.
出版: (2013-03-01)
Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report
由: Daniele Barbaro, et al.
出版: (2024-07-01)
由: Daniele Barbaro, et al.
出版: (2024-07-01)
Development of animal models to study aggressive thyroid cancers
由: Shovan Dutta, et al.
出版: (2025-02-01)
由: Shovan Dutta, et al.
出版: (2025-02-01)
Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice
由: Zhen Xu, et al.
出版: (2023-07-01)
由: Zhen Xu, et al.
出版: (2023-07-01)
Cascade-penetrating domino-ferroptosis nano inducer synergizes with sonodynamic therapy for anaplastic thyroid cancer
由: Peng Dong, et al.
出版: (2025-10-01)
由: Peng Dong, et al.
出版: (2025-10-01)
Anaplastic thyroid carcinoma case series
由: Nadire Küçüköztaş, et al.
出版: (2024-01-01)
由: Nadire Küçüköztaş, et al.
出版: (2024-01-01)
Photothermal induced chemo-immunological synergistic therapy for anaplastic thyroid carcinoma treatment
由: Bowen Chen, et al.
出版: (2023-05-01)
由: Bowen Chen, et al.
出版: (2023-05-01)
The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis
由: Hongen Guo, et al.
出版: (2024-03-01)
由: Hongen Guo, et al.
出版: (2024-03-01)
Neoadjuvant famitinib and camrelizumab, a new combined therapy allowing surgical resection of the primary site for anaplastic thyroid carcinoma
由: Shuwen Yang, et al.
出版: (2023-01-01)
由: Shuwen Yang, et al.
出版: (2023-01-01)
Rare clinical observation of pronounced response to immunotherapy in a patient with anaplastic thyroid cancer
由: D. M. Vontlaya, et al.
出版: (2024-06-01)
由: D. M. Vontlaya, et al.
出版: (2024-06-01)
Investigation of the Validity of UICC Stage Grouping of Anaplastic Carcinoma of the Thyroid
由: Yasuhiro Ito, et al.
出版: (2009-01-01)
由: Yasuhiro Ito, et al.
出版: (2009-01-01)
Evaluation of anaplastic thyroid carcinoma in the Kurdistan region of Iraq
由: Dilshad Hamad Mustafa, et al.
出版: (2022-10-01)
由: Dilshad Hamad Mustafa, et al.
出版: (2022-10-01)
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report
由: Cristina Luongo, et al.
出版: (2021-12-01)
由: Cristina Luongo, et al.
出版: (2021-12-01)
Therapeutic advances in anaplastic thyroid cancer: a current perspective
由: Shikha Saini, et al.
出版: (2018-10-01)
由: Shikha Saini, et al.
出版: (2018-10-01)
Unusual Manifestation of Anaplastic Thyroid Cancer
由: Vojtěch Haas, et al.
出版: (2008-01-01)
由: Vojtěch Haas, et al.
出版: (2008-01-01)
相似书籍
-
Anaplastic thyroid cancer: current state of the problem
由: P. A. Nikiforovich, et al.
出版: (2025-05-01) -
Systemic therapy for anaplastic thyroid cancer: a literature review
由: E. S. Dzhelialov, et al.
出版: (2025-01-01) -
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
由: Matthias Lang, et al.
出版: (2023-03-01) -
Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
由: A. L. Pylev, et al.
出版: (2020-04-01) -
Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas
由: A.C.L. Mortensen, et al.
出版: (2023-12-01)
